4//SEC Filing
Smith Jeffrey T L 4
Accession 0000950170-24-003065
CIK 0001937653other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:00 PM ET
Size
7.7 KB
Accession
0000950170-24-003065
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Smith Jeffrey T L
EVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-05+90,000→ 90,000 totalExercise: $10.56Exp: 2034-01-04→ Common Stock (90,000 underlying) - Award
Restricted Stock Unit
2024-01-05+60,000→ 60,000 total→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs vest in three equal annual installments beginning on January 5, 2025.
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001604800
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 6:00 PM ET
- Size
- 7.7 KB